Displaying 1 - 12 of 85
Viral Hepatitis
1

GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session) - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
1

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session) - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
1

GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session) - EASL Congress 2024

View
Viral Hepatitis
1

GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session) - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Displaying 1 - 12 of 85